<DOC>
	<DOCNO>NCT01524757</DOCNO>
	<brief_summary>Hereditary Hemochromatosis ( HH ) genetic disorder iron metabolism , result excessive iron overload cause damage different important organ like heart , liver , pancreas joint . Complications symptom regress intensive treatment reduce iron overload stores.Different gene identify play role pathophysiology iron overload . A clinically important HFE gene mutation C282Y , locate chromosome 6 . Phlebotomy currently standard therapy consist removal 500 ml whole blood weekly , represent loss 250 mg iron . In naive patient 20 100 phlebotomy require reduce serum ferritine level 50 μg/L . Thereafter , lifelong maintenance therapy 3 6 phlebotomy yearly need . For absorption , dietary iron ( 70 % ) reduce gastric acid form ferric ( Fe3+ ) ferrous form ( Fe2+ ) . Recently , observational open study , Hutchinson et al . find HH patient treat proton pump inhibitor ( PPI ) need few phlebotomy , result drop 2.5 ( SEM 0.25 ) 0.5 ( SEM 0.25 ) liter per year . Research question : The primary objective determine effectiveness cost effectiveness PPI 's compare standard phlebotomy therapy prevention iron overload HH patient . Multi-center trial two hospital South Limburg ( Atrium medical Center , Maastricht university medical center ) hospital Belgium ( University Hospital Gasthuisberg ) . The study conduct randomise double blind manner . The follow one year . Patients randomize either group receive PPI placebo . Every 2 month ferritin level measure decide patient need phlebotomy ( Ferritin &gt; 100 µg/L ) .</brief_summary>
	<brief_title>Proton Pump Inhibitors Prevention Iron Reaccumulation Patient With Hereditary Hemochromatosis</brief_title>
	<detailed_description />
	<mesh_term>Hemochromatosis</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients hereditary hemochromatosis ( HH ) , homozygous C282Y , currently treat phlebotomy maintenance therapy least 12 month ≥ 3 phlebotomy per year . Ferritin level 50100 μg/L start inclusion . Age : 18 year 60 year weight &gt; 50 kg . Patients receive therapy chelate therapy force dietary regimen . Patients young 18 year . HH patient excessive overweight ( BMI &gt; 35 ) . Patients mentally incapacitated . Women pregnant expecting/ planning become pregnant one year period study . Patients malignancy . Patients already PPI treatment . Patients experienced side effect PPI 's .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>